- Home
- IPAR vs SLNO Comparison
IPAR vs SLNO Comparison
Compare IPAR & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPAR
- SLNO
- Stock Information
- Founded
- IPAR 1982
- SLNO 1999
- Country
- IPAR United States
- SLNO United States
- Employees
- IPAR N/A
- SLNO N/A
- Industry
- IPAR Package Goods/Cosmetics
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- IPAR Consumer Discretionary
- SLNO Health Care
- Exchange
- IPAR Nasdaq
- SLNO Nasdaq
- Market Cap
- IPAR 4.2B
- SLNO 3.8B
- IPO Year
- IPAR 1988
- SLNO 2014
- Fundamental
- Price
- IPAR $135.50
- SLNO $82.27
- Analyst Decision
- IPAR Strong Buy
- SLNO Strong Buy
- Analyst Count
- IPAR 5
- SLNO 9
- Target Price
- IPAR $157.60
- SLNO $105.11
- AVG Volume (30 Days)
- IPAR 199.0K
- SLNO 1.4M
- Earning Date
- IPAR 08-05-2025
- SLNO 08-06-2025
- Dividend Yield
- IPAR 2.36%
- SLNO N/A
- EPS Growth
- IPAR 19.12
- SLNO N/A
- EPS
- IPAR 5.17
- SLNO N/A
- Revenue
- IPAR $1,467,181,000.00
- SLNO N/A
- Revenue This Year
- IPAR $5.90
- SLNO N/A
- Revenue Next Year
- IPAR $3.25
- SLNO N/A
- P/E Ratio
- IPAR $26.24
- SLNO N/A
- Revenue Growth
- IPAR 10.32
- SLNO N/A
- 52 Week Low
- IPAR $97.65
- SLNO $41.50
- 52 Week High
- IPAR $148.15
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- IPAR 53.80
- SLNO 51.33
- Support Level
- IPAR $133.65
- SLNO $79.70
- Resistance Level
- IPAR $139.00
- SLNO $90.32
- Average True Range (ATR)
- IPAR 3.40
- SLNO 3.66
- MACD
- IPAR -0.28
- SLNO -0.41
- Stochastic Oscillator
- IPAR 54.13
- SLNO 31.42
About IPAR Inter Parfums Inc.
Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.